Form 4 Tracker
PRECISION BIOSCIENCES INC
DTIL

25 insider filings · Latest: Sep 28, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 3, 2025Nov 3 8:15 PMAmoroso Michael
Proposed Sale
3,409$6.49$22.1K—

View →

Nov 3, 2025Nov 3 8:07 PMScimeca Dario
Proposed Sale
665$6.49$4.3K—

View →

Jul 3, 2025Jul 3 7:25 PMKelly John Alexander
Proposed Sale
14,827$4.26$63.2K—

View →

Mar 24, 2025Mar 24 7:13 PMAmoroso Michael
Proposed Sale
964$5.56$5.4K—

View →

Mar 5, 2025Mar 5 8:17 PMList Alan
Proposed Sale
333$5.06$1.7K—

View →

Mar 4, 2025Mar 4 9:15 PMSMITH J. JEFFERSON
Proposed Sale
154$4.91$756—

View →

Mar 4, 2025Mar 4 9:13 PMScimeca Dario
Proposed Sale
272$4.91$1.3K—

View →

Jan 24, 2025Jan 24 8:10 PMList Alan
Proposed Sale
672$5.04$3.4K—

View →

Jan 22, 2025Jan 22 8:14 PMScimeca Dario
Proposed Sale
8,928$4.79$42.7K—

View →

Jan 22, 2025Jan 22 8:13 PMSMITH J. JEFFERSON
Proposed Sale
10,287$4.79$49.2K—

View →

Jan 21, 2025Jan 21 9:19 PMAmoroso Michael
Proposed Sale
36,838$4.67$172.2K—

View →

Nov 4, 2024Nov 4 8:51 PMScimeca Dario
Proposed Sale
588$8.19$4.8K—

View →

Nov 4, 2024Nov 4 8:49 PMAmoroso Michael
Proposed Sale
3,012$8.19$24.7K—

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 3, 2026Jun 5 11:39 AMMelinda BrownDirector
Grant/Award
20,979—20,979(D)

View →

Jun 3, 2026Jun 5 11:38 AMStanley FrankelDirector
Grant/Award
20,979—20,979(D)

View →

Jun 3, 2026Jun 5 11:37 AMGeno J GermanoDirector
Grant/Award
20,979—20,979(D)

View →

Jun 3, 2026Jun 5 11:36 AMShari Lisa PireDirector
Grant/Award
20,979—20,979(D)

View →

Jun 3, 2026Jun 5 11:35 AMKevin BuehlerDirector
Grant/Award
20,979—20,979(D)

View →

Jun 1, 2026Jun 3 8:06 PMJefferson J. SmithChief Research Officer
Grant/Award
57,389—57,389(D)

View →

Jun 1, 2026Jun 3 8:06 PMDario ScimecaGeneral Counsel and Secretary
Grant/Award
107,604—107,604(D)

View →

Jun 1, 2026Jun 3 8:05 PMJohn Alexander KellyChief Financial Officer
Grant/Award
193,688—193,688(D)

View →

Jun 1, 2026Jun 3 8:05 PMMichael AmorosoDirector, President and CEO
Grant/Award
573,888—573,888(D)

View →

May 20, 2026May 22 11:31 AMKevin BuehlerDirector
Option Exercise
21,000—0(D)

View →

May 20, 2026May 22 11:31 AMStanley FrankelDirector
Option Exercise
21,000—0(D)

View →

May 20, 2026May 22 11:30 AMMelinda BrownDirector
Option Exercise
21,000—0(D)

View →

May 20, 2026May 22 11:30 AMShari Lisa PireDirector
Option Exercise
21,000—0(D)

View →

May 20, 2026May 22 11:30 AMGeno J GermanoDirector
Option Exercise
21,000—0(D)

View →

Feb 17, 2026Feb 19 9:31 PMMichael AmorosoDirector, President and CEO
Option Exercise
67,797—135,593(D)

View →

Feb 17, 2026Feb 19 9:31 PMJohn Alexander KellyChief Financial Officer
Option Exercise
27,584—55,166(D)

View →

Feb 17, 2026Feb 19 9:30 PMDario ScimecaGeneral Counsel and Secretary
Option Exercise
16,667—33,333(D)

View →

Feb 17, 2026Feb 19 9:30 PMJefferson J. SmithChief Research Officer
Option Exercise
16,667—33,333(D)

View →

Jan 20, 2026Jan 22 11:49 PMMichael AmorosoDirector, President and CEO
Option Exercise
115,378—69,421(D)

View →

Jan 20, 2026Jan 22 11:48 PMDario ScimecaGeneral Counsel and Secretary
Option Exercise
25,311—14,907(D)

View →

Page 1 of 2

Next →